Agreement Sra 5/1/2018-8/31/2018: $6,185 Agreement Sra 9/1/2018-8/31/2019: $16,555 Yr3 Amd 1: $26,595 Yr4 Amd 2: $24,468 Yr4 Amd 3: $38,221 Demetrio Sierra, Phd, Co-investigator and Mentee Will
Oral Health Services. Replaces contract # 1158142.
Intelligence Specialist
Support Operations Coordinator
Budget Analyst
Clinical Laboratory Regulatory Specialist
Dietitian (Clinical)
518-26-3-7077-0021: Dental Oral Imaging Equipment (VA-26-00046459)
Travel: 2026 Hilton Head Solid-State Sensors, Actuators and Microsystems Workshop
Conference: 2026 Salt and Water Stress in Plants GRC and GRS: Multi-Scale Mechanisms of Stress Resistance Leading to Agriculture and Ecosystem Insight; May 24-29, 2026 Switzerland
Molecular priming of reverse migration in neutrophil subpopulations
Regulation of nucleus accumbens microcircuitry by exogenous opioid exposure
A novel combination therapy for recurrent ovarian cancer
IRS Financial Reporting: Improvements Needed in Information System and Other Controls
Dr. Shijun Gao Will Collaborate With the Principal Investigator, Dr. Sean Cash, and Co-investigators Dr. Jessica Sparks (tufts University) and Dr. Jessica Gephart (university of Washington) on the Pro
Orfeu Buxton, Ph.d. Site Pi, Co-investigator (0.60 Calendar Months): Dr. Orfeu Buxton Director of the Actigraphy Data Coordinating Center, Is Co-i on This Project and Will Oversee All Aspects of Actig
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
100
100
50
100
100
Excellent opportunity — high volume, growing market, accessible to new entrants.